Explore the causes of generic drug quality failures, from cGMP violations and global supply chain gaps to the impact of pricing pressure on patient safety.
READ MORE
Clinicians are raising alarms about generic drug quality as manufacturing shifts overseas. With 54% higher adverse events linked to Indian-made generics and outdated facilities, the system is under strain. Transparency, domestic production, and modern manufacturing may be the keys to safer medications.
READ MORE